Health Care & Life Sciences » Biotechnology | Onconova Therapeutics Inc.

Onconova Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,753.00
800.00
11,456.00
5,546.00
787.00
1,228
SG&A Expense
66,526.00
64,110.00
35,278.00
29,153.00
26,436.00
24,455
EBIT
62,222.00
63,744.00
23,972.00
23,703.00
25,737.00
23,282
Unusual Expense
42.00
20.00
-
3,988.00
1,628.00
1,597
Non Operating Income/Expense
63.00
50.00
35.00
62.00
30.00
1,151
Interest Expense
4.00
2.00
-
-
-
-
Pretax Income
62,121.00
63,776.00
24,007.00
19,653.00
24,079.00
20,534
Income Tax
435.00
19.00
16.00
14.00
13.00
124
Consolidated Net Income
64,876.00
63,795.00
24,023.00
19,667.00
24,092.00
20,410
Net Income
64,863.00
63,682.00
23,979.00
19,667.00
24,092.00
20,573
Net Income After Extraordinaries
64,863.00
63,682.00
23,979.00
19,667.00
24,092.00
20,573
Net Income Available to Common
64,863.00
63,682.00
23,979.00
19,667.00
24,092.00
20,573
EPS (Basic)
61.20
29.40
10.50
4.44
2.68
4.99
Basic Shares Outstanding
1,059.40
2,165.40
2,274.00
4,426.60
9,000.30
4,124.10
EPS (Diluted)
61.22
29.41
10.54
4.44
2.68
4.99
Diluted Shares Outstanding
1,059.40
2,165.40
2,274.00
4,426.60
9,000.30
4,124.10
EBITDA
61,773.00
63,310.00
23,822.00
23,607.00
25,649.00
23,227
Minority Interest Expense
13.00
113.00
44.00
-
-
163
Other After Tax Income (Expense)
2,320.00
-
-
-
-
-

About Onconova Therapeutics

View Profile
Address
375 Pheasant Run
Newtown Pennsylvania 18940
United States
Employees -
Website http://www.onconova.com
Updated 07/08/2019
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.